KBC Group NV Invests $317,000 in Astera Labs, Inc. $ALAB

KBC Group NV bought a new stake in shares of Astera Labs, Inc. (NASDAQ:ALAB - Free Report) during the 2nd quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The institutional investor bought 3,508 shares of the company's stock, valued at approximately $317,000.

• Follow the Money: 3 Stocks With High Institutional Ownership

Several other large investors have also added to or reduced their stakes in ALAB. Oliver Lagore Vanvalin Investment Group acquired a new position in Astera Labs in the second quarter valued at approximately $29,000. Bernard Wealth Management Corp. bought a new stake in shares of Astera Labs in the 2nd quarter valued at $36,000. Harbour Investments Inc. lifted its position in shares of Astera Labs by 351.7% during the 1st quarter. Harbour Investments Inc. now owns 795 shares of the company's stock valued at $47,000 after acquiring an additional 619 shares during the period. Hazlett Burt & Watson Inc. boosted its stake in Astera Labs by 1,670.0% during the first quarter. Hazlett Burt & Watson Inc. now owns 885 shares of the company's stock worth $53,000 after acquiring an additional 835 shares in the last quarter. Finally, Ameritas Advisory Services LLC bought a new position in Astera Labs during the second quarter worth $64,000. Institutional investors and hedge funds own 60.47% of the company's stock.

Insider Transactions at Astera Labs

In related news, Director Manuel Alba sold 183,000 shares of the business's stock in a transaction dated Tuesday, September 2nd. The shares were sold at an average price of $173.27, for a total transaction of $31,708,410.00. Following the transaction, the director directly owned 385,863 shares in the company, valued at approximately $66,858,482.01. The trade was a 32.17% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link. Also, General Counsel Philip Mazzara sold 10,000 shares of the stock in a transaction dated Wednesday, October 1st. The shares were sold at an average price of $192.16, for a total transaction of $1,921,600.00. Following the completion of the sale, the general counsel owned 151,573 shares of the company's stock, valued at approximately $29,126,267.68. This trade represents a 6.19% decrease in their position. The disclosure for this sale is available in the SEC filing. Insiders sold a total of 225,500 shares of company stock worth $39,531,460 in the last quarter. 12.50% of the stock is currently owned by corporate insiders.

Astera Labs Stock Performance

• Are These 3 Beaten-Down Stocks Ready to Rebound?

Shares of ALAB opened at $141.39 on Tuesday. The firm has a market capitalization of $23.88 billion, a P/E ratio of 127.38, a P/E/G ratio of 2.69 and a beta of 1.38. Astera Labs, Inc. has a 52 week low of $47.13 and a 52 week high of $262.90. The stock has a 50 day moving average price of $192.00 and a two-hundred day moving average price of $144.85.

Astera Labs (NASDAQ:ALAB - Get Free Report) last announced its earnings results on Tuesday, November 4th. The company reported $0.49 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.39 by $0.10. Astera Labs had a return on equity of 13.48% and a net margin of 27.50%.The company had revenue of $230.58 million for the quarter, compared to analysts' expectations of $206.42 million. During the same quarter in the previous year, the firm earned $0.23 earnings per share. Astera Labs's quarterly revenue was up 103.9% on a year-over-year basis. Astera Labs has set its Q4 2025 guidance at 0.50-0.510 EPS. On average, equities analysts forecast that Astera Labs, Inc. will post 0.34 earnings per share for the current year.

Analysts Set New Price Targets

• 4 Stocks Every AI ETF Is Buying—And They’re Not What You Think

ALAB has been the subject of several research analyst reports. Zacks Research downgraded shares of Astera Labs from a "strong-buy" rating to a "hold" rating in a research note on Monday, October 6th. Susquehanna boosted their target price on Astera Labs from $80.00 to $125.00 and gave the company a "neutral" rating in a research report on Thursday, August 7th. Citigroup upped their price target on Astera Labs from $160.00 to $275.00 and gave the stock a "buy" rating in a research note on Wednesday, September 17th. TD Cowen reduced their price objective on Astera Labs from $225.00 to $170.00 and set a "hold" rating for the company in a research note on Wednesday, November 5th. Finally, Stifel Nicolaus upped their target price on Astera Labs from $185.00 to $200.00 and gave the stock a "buy" rating in a research report on Wednesday, November 5th. Fourteen research analysts have rated the stock with a Buy rating and eight have given a Hold rating to the company's stock. According to data from MarketBeat, the stock presently has a consensus rating of "Moderate Buy" and a consensus price target of $184.82.

Read Our Latest Research Report on Astera Labs

About Astera Labs

Astera Labs, Inc designs, manufactures, and sells semiconductor-based connectivity solutions for cloud and AI infrastructure. Its Intelligent Connectivity Platform is comprised of a portfolio of data, network, and memory connectivity products, which are built on a unifying software-defined architecture that enables customers to deploy and operate high performance cloud and AI infrastructure at scale.

Featured Stories

• Five stocks we like better than Astera Labs
• Uptrend Stocks Explained: Learn How to Trade Using Uptrends
• Whirlpool’s Worst May Be Over—Upside Opportunity Ahead
• Short Selling - The Pros and Cons
• These 3 Beaten-Down Stocks Could Be Your Best Buying Opportunity This Quarter
• Stock Average Calculator
• How Does D-Wave Stack Up to Quantum Rivals After Earnings Season?

Want to see what other hedge funds are holding ALAB? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Astera Labs, Inc. (NASDAQ:ALAB - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Should You Invest $1,000 in Astera Labs Right Now?

Before you consider Astera Labs, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Astera Labs wasn't on the list.

While Astera Labs currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here